Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

A comparison of outcomes and complications of totally implantable access port through the internal jugular vein versus the subclavian vein.

Nagasawa Y, Shimizu T, Sonoda H, Mekata E, Wakabayashi M, Ohta H, Murata S, Mori T, Naka S, Tani T.

Int Surg. 2014 Mar-Apr;99(2):182-8. doi: 10.9738/INTSURG-D-13-00185.1.

2.

Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception.

Plumhans C, Mahnken AH, Ocklenburg C, Keil S, Behrendt FF, Günther RW, Schoth F.

Eur J Radiol. 2011 Sep;79(3):338-42. doi: 10.1016/j.ejrad.2009.12.010. Epub 2010 Mar 12.

PMID:
20227211
3.

Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience.

Charvát J, Linke Z, Horáèková M, Prausová J.

Support Care Cancer. 2006 Nov;14(11):1162-5. Epub 2006 Apr 5.

PMID:
16596418
4.

Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture.

Ribeiro RC, Abib SC, Aguiar AS, Schettini ST.

Pediatr Blood Cancer. 2012 Feb;58(2):274-7. doi: 10.1002/pbc.23220. Epub 2011 Jun 14.

PMID:
21674765
5.

[Totally implantable central venous access devices in patients with cancer. Experience at a private oncology center].

Cortés-Flores AO, Morgan-Villela G, Juárez-Uzeta EA, Fuentes-Orozco C, Jiménez-Tornero J, González-Ojeda A.

Cir Cir. 2012 Sep-Oct;80(5):429-34. Spanish.

PMID:
23351446
6.

Conversion from cephalic vein to external jugular vein: success rate increased on totally implantable access ports with cut-down method.

Lin CH, Yu JC, Lee YT, Wu HS.

Surg Innov. 2013 Dec;20(6):566-9. doi: 10.1177/1553350613479178. Epub 2013 Feb 26.

PMID:
23445713
7.

Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.

Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, Della Vigna P, Rotmensz N, Radice D, Zampino MG, Fazio N, de Braud F, Andreoni B, Goldhirsch A.

Ann Oncol. 2009 May;20(5):935-40. doi: 10.1093/annonc/mdn701. Epub 2009 Jan 29.

PMID:
19179550
8.

Upper body central venous catheters in pediatric cardiac surgery.

Miller JW, Vu DN, Chai PJ, Kreutzer JH, John JB, Vener DF, Jacobs JP.

Paediatr Anaesth. 2013 Nov;23(11):980-8. doi: 10.1111/pan.12261. Epub 2013 Sep 19.

PMID:
24088201
9.
10.

A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.

Araújo C, Silva JP, Antunes P, Fernandes JM, Dias C, Pereira H, Dias T, Fougo JL.

Eur J Surg Oncol. 2008 Feb;34(2):222-6. Epub 2007 Jun 12.

PMID:
17566692
11.

Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement.

Song MG, Seo TS, Kang EY, Yong HS, Seo JH, Choi YY.

J Vasc Access. 2015 Jul-Aug;16(4):315-20. doi: 10.5301/jva.5000387. Epub 2015 Apr 27.

PMID:
25953212
12.

Use of a totally implantable access port through the external jugular vein when the cephalic vein approach is not feasible.

Lin YC, Chu CH, Ou KW, Chan DC, Hsieh CB, Chen TW, Hsu HM, Yu JC.

Ann Vasc Surg. 2011 Feb;25(2):217-21. doi: 10.1016/j.avsg.2010.07.017. Epub 2010 Oct 6.

PMID:
20926248
13.

Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.

Seiler CM, Frohlich BE, Dorsam UJ, Kienle P, Buchler MW, Knaebel HP.

J Surg Oncol. 2006 Jan 1;93(1):24-9.

PMID:
16353193
14.

Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access.

Trerotola SO, Kuhn-Fulton J, Johnson MS, Shah H, Ambrosius WT, Kneebone PH.

Radiology. 2000 Oct;217(1):89-93.

PMID:
11012428
15.

Usefulness of Groshong catheters for central venous access via the external jugular vein.

Ishizuka M, Nagata H, Takagi K, Horie T, Sawada T, Kubota K.

J Invest Surg. 2008 Jan-Feb;21(1):9-14. doi: 10.1080/08941930701833447.

PMID:
18197529
16.

[Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].

Hoareau-Gruchet F, Rtail R, Sulaj H, Khirnetkina A, Reyt E, Righini CA.

Ann Otolaryngol Chir Cervicofac. 2009 Apr;126(2):43-52. doi: 10.1016/j.aorl.2009.02.005. Epub 2009 Mar 25. French.

PMID:
19324328
17.

Factors that predict increased catheter tip movement in left internal jugular vein implantable venous access ports upon standing.

Wallace JA, Afonso E, Yu H, Birchard K, Isaacson A.

J Vasc Access. 2015 May-Jun;16(3):223-6. doi: 10.5301/jva.5000331. Epub 2015 Jan 17.

PMID:
25613147
18.

Application of an ultrasound-guided low-approach insertion technique in three types of totally implantable access port.

Cheng HW, Ting CK, Chu YC, Chang WK, Chan KH, Chen PT.

J Chin Med Assoc. 2014 May;77(5):246-52. doi: 10.1016/j.jcma.2014.02.005. Epub 2014 Apr 13.

19.

Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial.

Biffi R, Pozzi S, Bonomo G, Della Vigna P, Monfardini L, Radice D, Rotmensz N, Zampino MG, Fazio N, Orsi F.

Ann Surg Oncol. 2014 Nov;21(12):3725-31. doi: 10.1245/s10434-014-3784-5. Epub 2014 May 20.

PMID:
24841352
20.

Randomized clinical trial comparing ultrasound-guided procedure with the Seldinger's technique for placement of implantable venous ports.

Miao J, Ji L, Lu J, Chen J.

Cell Biochem Biophys. 2014 Sep;70(1):559-63. doi: 10.1007/s12013-014-9956-x.

PMID:
24748179

Supplemental Content

Support Center